1. Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R: ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013, 2014 (129): S49-73.
2. Stone NJ, Robinson JG, Lichtenstein AH, Bairey MCN, Blum CB, Eckel RH: ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013, 2014 (63): 2889-934.
3. Lopez-Jimenez F, Simha V, Thomas RJ, Allison TG, Basu A, Fernandes R: A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps. Mayo Clin Proc. 2014, 89: 1257-78. 10.1016/j.mayocp.2014.06.016
4. Smith SC, Grundy SM: ACC/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol. J Am Coll Cardiol. 2013, 2014 (64): 601-12.
5. Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Boren J, Catapano AL: Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J. 2011, 32: 1345-61. 10.1093/eurheartj/ehr112